SVB Wealth’s VanEck Biotech ETF BBH Stock Holding History

SVB Wealth’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-569	Closed	-$89.5K	–	616
2025 Q1	$89.5K	Buy	+569	New	+$92.4K	﹤0.01%	428

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SVB Wealth's BBH Position: Q2 2025 in Review

SVB Wealth sold out of VanEck Biotech ETF (BBH) in Q2 2025, closing a stake of 569 shares — an estimated $89.5K sold.

SVB Wealth first reported a position in BBH in Q1 2025 and held it in 1 quarter. The position peaked at $89.5K in Q1 2025. 98 funds tracked by Wall St. Rank hold BBH as of Q2 2025.

SVB Wealth reported no remaining VanEck Biotech ETF position as of Q2 2025 after selling out during the quarter.
SVB Wealth sold 569 VanEck Biotech ETF shares in Q2 2025, an estimated $89.5K.
SVB Wealth first reported a position in VanEck Biotech ETF in Q1 2025 and held it in 1 quarter.
SVB Wealth's VanEck Biotech ETF position peaked at $89.5K in Q1 2025.
98 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2025.

Based on SVB Wealth's 13F filing for Q2 2025, filed 14 Aug 2025.